• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微管蛋白抑制剂:基于细胞数据的化学信息学分析

Tubulin Inhibitors: A Chemoinformatic Analysis Using Cell-Based Data.

作者信息

López-López Edgar, Cerda-García-Rojas Carlos M, Medina-Franco José L

机构信息

Departamento de Química y Programa de Posgrado en Farmacología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Apartado 14-740, Mexico City 07000, Mexico.

DIFACQUIM Research Group, Department of Pharmacy, School of Chemistry, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.

出版信息

Molecules. 2021 Apr 24;26(9):2483. doi: 10.3390/molecules26092483.

DOI:10.3390/molecules26092483
PMID:33923169
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8123128/
Abstract

Inhibiting the tubulin-microtubules (Tub-Mts) system is a classic and rational approach for treating different types of cancers. A large amount of data on inhibitors in the clinic supports Tub-Mts as a validated target. However, most of the inhibitors reported thus far have been developed around common chemical scaffolds covering a narrow region of the chemical space with limited innovation. This manuscript aims to discuss the first activity landscape and scaffold content analysis of an assembled and curated cell-based database of 851 Tub-Mts inhibitors with reported activity against five cancer cell lines and the Tub-Mts system. The structure-bioactivity relationships of the Tub-Mts system inhibitors were further explored using constellations plots. This recently developed methodology enables the rapid but quantitative assessment of analog series enriched with active compounds. The constellations plots identified promising analog series with high average biological activity that could be the starting points of new and more potent Tub-Mts inhibitors.

摘要

抑制微管蛋白-微管(Tub-Mts)系统是治疗不同类型癌症的经典且合理的方法。临床上大量关于抑制剂的数据支持Tub-Mts作为一个经过验证的靶点。然而,迄今为止报道的大多数抑制剂都是围绕常见化学骨架开发的,这些骨架覆盖的化学空间区域狭窄,创新有限。本手稿旨在讨论一个经过组装和整理的基于细胞的数据库的首次活性景观和支架内容分析,该数据库包含851种Tub-Mts抑制剂,这些抑制剂对五种癌细胞系和Tub-Mts系统具有报道的活性。使用星座图进一步探索了Tub-Mts系统抑制剂的结构-生物活性关系。这种最近开发的方法能够快速但定量地评估富含活性化合物的类似物系列。星座图确定了具有高平均生物活性的有前景的类似物系列,这些系列可能是新型更强效Tub-Mts抑制剂的起点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054f/8123128/395b7bc5c77d/molecules-26-02483-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054f/8123128/4245023be5fe/molecules-26-02483-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054f/8123128/f7d3a221ccdc/molecules-26-02483-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054f/8123128/d591a04b0397/molecules-26-02483-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054f/8123128/59a020442723/molecules-26-02483-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054f/8123128/7e9a0747b791/molecules-26-02483-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054f/8123128/aa9f5d8401f5/molecules-26-02483-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054f/8123128/395b7bc5c77d/molecules-26-02483-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054f/8123128/4245023be5fe/molecules-26-02483-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054f/8123128/f7d3a221ccdc/molecules-26-02483-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054f/8123128/d591a04b0397/molecules-26-02483-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054f/8123128/59a020442723/molecules-26-02483-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054f/8123128/7e9a0747b791/molecules-26-02483-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054f/8123128/aa9f5d8401f5/molecules-26-02483-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/054f/8123128/395b7bc5c77d/molecules-26-02483-g007.jpg

相似文献

1
Tubulin Inhibitors: A Chemoinformatic Analysis Using Cell-Based Data.微管蛋白抑制剂:基于细胞数据的化学信息学分析
Molecules. 2021 Apr 24;26(9):2483. doi: 10.3390/molecules26092483.
2
Consensus Virtual Screening Protocol Towards the Identification of Small Molecules Interacting with the Colchicine Binding Site of the Tubulin-microtubule System.针对与微管系统中的秋水仙素结合位点相互作用的小分子的共识虚拟筛选协议。
Mol Inform. 2023 Jan;42(1):e2200166. doi: 10.1002/minf.202200166. Epub 2022 Oct 19.
3
Molecular dynamics simulation and free energy landscape methods in probing L215H, L217R and L225M βI-tubulin mutations causing paclitaxel resistance in cancer cells.分子动力学模拟和自由能景观方法用于探究导致癌细胞对紫杉醇耐药的βI-微管蛋白L215H、L217R和L225M突变
Biochem Biophys Res Commun. 2016 Aug 5;476(4):273-279. doi: 10.1016/j.bbrc.2016.05.112. Epub 2016 May 24.
4
Design, Synthesis and Cancer Cell Growth Inhibition Evaluation of New Aminoquinone Hybrid Molecules.新型氨基醌杂化分子的设计、合成及抗癌细胞生长抑制活性评价。
Molecules. 2019 Jun 14;24(12):2224. doi: 10.3390/molecules24122224.
5
Tubulin inhibitors as novel anticancer agents: an overview on patents (2013-2018).微管蛋白抑制剂作为新型抗癌药物:专利概述(2013-2018 年)。
Expert Opin Ther Pat. 2019 Aug;29(8):623-641. doi: 10.1080/13543776.2019.1648433. Epub 2019 Aug 4.
6
Molecular modelling studies on Arylthioindoles as potent inhibitors of tubulin polymerization.芳基硫代吲哚作为微管蛋白聚合抑制剂的分子建模研究。
Eur J Med Chem. 2011 Aug;46(8):3519-25. doi: 10.1016/j.ejmech.2011.05.020. Epub 2011 May 13.
7
Selective targeting of tumorigenic cancer cell lines by microtubule inhibitors.微管抑制剂对致瘤性癌细胞系的选择性靶向作用。
PLoS One. 2009;4(2):e4470. doi: 10.1371/journal.pone.0004470. Epub 2009 Feb 13.
8
Structural comparison of the interaction of tubulin with various ligands affecting microtubule dynamics.各种影响微管动态的配体与微管蛋白相互作用的结构比较。
Curr Cancer Drug Targets. 2012 Jul;12(6):658-66. doi: 10.2174/156800912801784893.
9
Discovery of novel tubulin inhibitors targeting taxanes site by virtual screening, molecular dynamic simulation, and biological evaluation.通过虚拟筛选、分子动力学模拟和生物评估发现新型靶向紫杉烷类药物结合位点的微管蛋白抑制剂。
J Cell Biochem. 2021 Nov;122(11):1609-1624. doi: 10.1002/jcb.30077. Epub 2021 Jul 8.
10
Discovery of novel N-benzylbenzamide derivatives as tubulin polymerization inhibitors with potent antitumor activities.发现新型 N-苄基苯甲酰胺衍生物作为具有强效抗肿瘤活性的微管蛋白聚合抑制剂。
Eur J Med Chem. 2021 Apr 15;216:113316. doi: 10.1016/j.ejmech.2021.113316. Epub 2021 Feb 24.

引用本文的文献

1
Molecular similarity: Theory, applications, and perspectives.分子相似性:理论、应用与展望。
Artif Intell Chem. 2024 Dec;2(2). doi: 10.1016/j.aichem.2024.100077. Epub 2024 Aug 31.
2
Targeting TUBG1 in RB1-negative tumors.针对RB1阴性肿瘤中的TUBG1
FASEB J. 2025 Mar 15;39(5):e70431. doi: 10.1096/fj.202403180RR.
3
Art driven by visual representations of chemical space.由化学空间的视觉表征驱动的艺术。

本文引用的文献

1
Synthesis and biological evaluation of 2-aryl-benzimidazole derivatives of dehydroabietic acid as novel tubulin polymerization inhibitors.脱氢枞酸的2-芳基苯并咪唑衍生物作为新型微管蛋白聚合抑制剂的合成及生物学评价
RSC Adv. 2018 May 16;8(31):17511-17526. doi: 10.1039/c8ra02078g. eCollection 2018 May 9.
2
From Qualitative to Quantitative Analysis of Activity and Property Landscapes.从活动和性质景观的定性分析到定量分析。
J Chem Inf Model. 2020 Dec 28;60(12):5873-5880. doi: 10.1021/acs.jcim.0c01249. Epub 2020 Nov 18.
3
Design, synthesis and evaluation of antiproliferative and antitubulin activities of 5-methyl-4-aryl-3-(4-arylpiperazine-1-carbonyl)-4H-1,2,4-triazoles.
J Cheminform. 2023 Oct 21;15(1):100. doi: 10.1186/s13321-023-00770-4.
4
Towards Decoding Hepatotoxicity of Approved Drugs through Navigation of Multiverse and Consensus Chemical Spaces.通过多元宇宙和共识化学空间的导航来解码已批准药物的肝毒性。
Biomolecules. 2023 Jan 14;13(1):176. doi: 10.3390/biom13010176.
5
Two Important Anticancer Mechanisms of Natural and Synthetic Chalcones.天然和合成查尔酮的两种重要抗癌机制。
Int J Mol Sci. 2022 Sep 30;23(19):11595. doi: 10.3390/ijms231911595.
6
Consensus Virtual Screening Protocol Towards the Identification of Small Molecules Interacting with the Colchicine Binding Site of the Tubulin-microtubule System.针对与微管系统中的秋水仙素结合位点相互作用的小分子的共识虚拟筛选协议。
Mol Inform. 2023 Jan;42(1):e2200166. doi: 10.1002/minf.202200166. Epub 2022 Oct 19.
7
characterization and rational analog design of a novel inhibitor of telomerase assembly in MDA MB 231 breast cancer cell line.在 MDA-MB-231 乳腺癌细胞系中鉴定和合理模拟新型端粒酶组装抑制剂。
Oncol Rep. 2022 Nov;48(5). doi: 10.3892/or.2022.8403. Epub 2022 Sep 14.
8
Progress on open chemoinformatic tools for expanding and exploring the chemical space.用于拓展和探索化学空间的开放 chemoinformatic 工具的进展。
J Comput Aided Mol Des. 2022 May;36(5):341-354. doi: 10.1007/s10822-021-00399-1. Epub 2021 Jun 18.
设计、合成及 5-甲基-4-芳基-3-(4-芳基哌嗪-1-羰基)-4H-1,2,4-三唑类化合物的抗增殖和抗微管蛋白活性评价。
Bioorg Chem. 2020 Nov;104:103909. doi: 10.1016/j.bioorg.2020.103909. Epub 2020 May 4.
4
Synthesis, and biological evaluation of 3,6-diaryl-[1,2,4]triazolo[4,3-a]pyridine analogues as new potent tubulin polymerization inhibitors.合成及 3,6-二芳基-[1,2,4]三唑并[4,3-a]嘧啶类似物作为新型强效微管蛋白聚合抑制剂的生物评价。
Eur J Med Chem. 2020 Oct 15;204:112625. doi: 10.1016/j.ejmech.2020.112625. Epub 2020 Jul 19.
5
Synthesis and biological evaluation of benzofuran-based 3,4,5-trimethoxybenzamide derivatives as novel tubulin polymerization inhibitors.苯并呋喃基 3,4,5-三甲氧基苯甲酰胺衍生物的合成及作为新型微管聚合抑制剂的生物评价。
Bioorg Chem. 2020 Sep;102:104076. doi: 10.1016/j.bioorg.2020.104076. Epub 2020 Jul 7.
6
Design, synthesis, and bioevaluation of pyrazolo[1,5-a]pyrimidine derivatives as tubulin polymerization inhibitors targeting the colchicine binding site with potent anticancer activities.设计、合成并评价吡唑并[1,5-a]嘧啶衍生物作为微管蛋白聚合抑制剂,以秋水仙碱结合位点为作用靶点,具有很强的抗癌活性。
Eur J Med Chem. 2020 Sep 15;202:112519. doi: 10.1016/j.ejmech.2020.112519. Epub 2020 Jun 27.
7
Design, synthesis, in vitro and in vivo biological evaluation of 2-amino-3-aroylbenzo[b]furan derivatives as highly potent tubulin polymerization inhibitors.设计、合成、体外和体内生物评价 2-氨基-3-芳酰基苯并[b]呋喃衍生物作为高效的微管聚合抑制剂。
Eur J Med Chem. 2020 Aug 15;200:112448. doi: 10.1016/j.ejmech.2020.112448. Epub 2020 May 12.
8
Discovery of a chiral fluorinated azetidin-2-one as a tubulin polymerisation inhibitor with potent antitumour efficacy.发现一种手性氟化氮杂环丁烷-2-酮作为微管蛋白聚合抑制剂,具有强大的抗肿瘤功效。
Eur J Med Chem. 2020 Jul 1;197:112323. doi: 10.1016/j.ejmech.2020.112323. Epub 2020 Apr 18.
9
Tubulin inhibitors: Discovery of a new scaffold targeting extra-binding residues within the colchicine site through anchoring substituents properly adapted to their pocket by a semi-flexible linker.微管蛋白抑制剂:通过半柔性连接子将适当适应其口袋的锚固取代基锚定在秋水仙碱结合位点的额外结合残基上,从而发现新的支架。
Bioorg Chem. 2020 Jun;99:103767. doi: 10.1016/j.bioorg.2020.103767. Epub 2020 Apr 6.
10
Ligand- and structural-based discovery of potential small molecules that target the colchicine site of tubulin for cancer treatment.基于配体和结构的研究发现了潜在的小分子,这些小分子以微管蛋白的秋水仙碱结合位点为靶点,可用于癌症治疗。
Eur J Med Chem. 2020 Jun 15;196:112328. doi: 10.1016/j.ejmech.2020.112328. Epub 2020 Apr 13.